A federal vaccine advisory panel is expected to vote to recommend delaying until age 4 the hepatitis B vaccine, currently given to newborns.
A federal vaccine advisory panel is expected to vote to recommend delaying until age 4 the hepatitis B vaccine, currently given to newborns.